Paving the way for liquid biopsy
Innovation for progress
Across analytesWe develop proven technologies to stabilize, extract and analyze circulating cell-free nucleic acids, exosomes and CTCs from blood, urine and other biofluids.
Across fieldsWe are committed to working with researchers, pathologists and clinicians to ensure that today’s biomarker discoveries become tomorrow’s clinical breakthroughs.
Across technologiesWe use advanced chemistries, sequencing technologies, automated platforms and interpretation tools to ensure you get meaningful results from your liquid biopsy samples.
Across workflowsWe create robust Sample to Insight solutions to offer you a broad portfolio of tools to improve standardization, sensitivity and specificity at every step of your workflow.
Latest – Get news, updates and stories
Expert’s view on the advances and challenges of liquid biopsyInterview with Prof. Klaus Pantel
Multi-analyte analysis gives more insights from less sampleInterview with Dr Corinna Keup
Collaborations to bring liquid biopsy to clinical practiceInterview with Prof. Klaus Pantel and Dr. Thomas Schlange
A Sample to Insight liquid biopsy workflow
Sample collection & stabilizationEnsure long-term stability of markers and eliminate analysis errors caused transportation and storage.
Sample preparationAchieved the highest yield and purity of circulating nucleic acids, exosomes and CTCs.
NGS & PCR analysisFocus on relevant markers and gene expression signatures with targeted sequencing and validated PCR assays.
Data analysisIdentify low-frequency variants and determine changes in expression with high accuracy.
Data interpretationGenerate biological hypotheses and uncover the significance of ‘omics data to identify new targets or candidate biomarkers.
Let us do the heavy lifting
Use our expert-led service solutions and get more time to spend on your interests
Featured – Dive deeper into liquid biopsy
Explore our Cancer Research Hub
Accelerate your journey to insights and help conquer cancer